Lymphocytes and Pancreatic Cancer: The Effects of These Cells on Diagnosis and Patient Survival

  • Raffaele Pezzilli Pancreas Unit, Department of Digestive Diseases and Internal Medicine, Sant’Orsola-Malpighi Hospital, “Alma Mater Studiorum - University of Bologna”. Bologna, Italy
  • Dario Fabbri Pancreas Unit, Department of Digestive Diseases and Internal Medicine, Sant’Orsola-Malpighi Hospital, “Alma Mater Studiorum - University of Bologna”. Bologna, Italy
  • Andrea Imbrogno Pancreas Unit, Department of Digestive Diseases and Internal Medicine, Sant’Orsola-Malpighi Hospital, “Alma Mater Studiorum - University of Bologna”. Bologna, Italy
Keywords: Lymphocytes, Pancreatic Neoplasms, Prognosis, Survival

Downloads

Download data is not yet available.

References

Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-7. [PMID 12490959]

Farrow B, Evers M. Inflammation and the development of pancreatic cancer. Surg Oncol 2002; 10:153-69. [PMID 12020670]

Algül H, Treiber M, Lesina M, Schmid RM. Mechanisms of disease: chronic inflammation and cancer in the pancreas-a potential role for pancreatic stellate cells? Nature Clin Pract Gastroenterol Hepatol 2007; 4:454-62. [PMID 17667994]

Greer JB, Whitcomb DC. Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol 2009; 9:411-8. [PMID 19589727]

Maletzki C, Emmrich J. Inflammation and immunity in the tumor environment. Dig Dis 2010; 28:574-8. [PMID 21088404]

Pezzilli R, Barassi A, Corsi MM, Morselli-Labate AM, Campana D, Casadei R, et al. Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms. Scand J Gastroenterol 2010; 45:93-9. [PMID 19883273]

Pezzilli R, Corsi MM, Barassi A, Morselli-Labate AM, Dogliotti G, Casadei R, et al. The role of inflammation in patients with intraductal mucinous neoplasm of the pancreas and in those with pancreatic adenocarcinoma. Anticancer Res 2010; 30:3801-5. [PMID 20944173]

Funel N, Costa F, Pettinari L, Taddeo A, Sala A, Chiriva-Internati M, et al. Ukrain affects pancreas cancer cell phenotype in vitro by targeting MMP-9 and intra-/extracellular SPARC expression. Pancreatology 2010; 10:545-52. [PMID 20975318]

Gnerlich JL, Mitchem JB, Weir JS, Sankpal NV, Kashiwagi H, Belt BA, et al. Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer. J Immunol 2010; 185:4063-71. [PMID 20805420]

Baine MJ, Chakraborty S, Smith LM, Mallya K, Sasson AR, Brand RE, Batra SK. Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. PLoS One 2011; 6:e17014. [PMID 21347333]

De Monte L, Reni M, Tassi E, Clavenna D, Papa I, Recalde H, et al. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 2011; 208:469-78. [PMID 21339327]

Pancreas News
Published
2011-03-09
How to Cite
PezzilliR., FabbriD., & ImbrognoA. (2011). Lymphocytes and Pancreatic Cancer: The Effects of These Cells on Diagnosis and Patient Survival. JOP. Journal of the Pancreas, 12(2), 209-210. https://doi.org/10.6092/1590-8577/3357
Section
PANCREAS NEWS